Olympus Appoints New CEO
TOKYO, JAPAN - April 25, 2025 ( NEWMEDIAWIRE ) - Olympus Corporation (Olympus), a global MedTech company committed to making people's lives healthier, safer and more fulfilling, today announces appointment of a Chief Executive Officer (CEO) aimed at accelerating its ongoing transformation efforts in the medtech space.
The Board of Directors has decided unanimously to appoint Bob White, a former Executive Vice President and President, Medical Surgical Portfolio for Medtronic, as a successor to Yasuo Takeuchi, Olympus' Director, Representative Executive Officer, President and CEO, effective June 1, 2025. Bob will also be proposed as a candidate for election to the Board at Olympus' General Meeting of Shareholders scheduled to be held in June 2025.
'We are pleased to name Bob to this pivotal leadership role. He possesses a wealth of experience garnered from his tenure at various esteemed organizations within the medical technology sector. I look forward to welcoming him as a leader who will bring extensive knowledge and expertise to the company,' said Yasuo Takeuchi. 'Over the course of his career, Bob has demonstrated exceptional leadership in driving both transformative growth and strategic initiatives. I am truly pleased that he is bringing this profound expertise and insight to Olympus.'
Comment from Bob White
'I am truly honored and grateful for the trust placed in me by the Board of Directors and the Nominating Committee. Olympus is an exceptional company, known for its market-leading solutions, cutting-edge technology, and remarkable people. I'm excited to bring my experience to the table and contribute to the company's ongoing success and growth. I've long admired Olympus for its rich Japanese heritage, outstanding products, and unwavering commitment to serving the needs of both clinicians and patients.'
Bob most recently served as Executive Vice President and President, Medical Surgical Portfolio for Medtronic until April 2024. Before then, he was Senior Vice President and President of Medtronic Asia Pacific, based in Singapore where he had responsibility for APAC as well as Japan. During his tenure at Covidien, he held the positions of President of Emerging Markets and President of Respiratory and Monitoring Solutions. He has seen numerous innovation programs and led several R&D initiatives and M&A transactions within complex business portfolios. His close engagement with the market and customers has enabled him to maintain a strong understanding of physician needs.
Prior to joining Medtronic, Bob held leadership positions at GE Healthcare, Merge Healthcare and Healthcare Division, IBM. Throughout his career in the medtech industry, he has played a pivotal role in improving the lives of patients around the world through the transformation of healthcare delivery.
In order to select and recommend the best candidate for the next CEO, the Nominating Committee engaged a leading executive search firm and formed an Advisory Search Committee in November 2024. After a comprehensive and rigorous search process, Olympus determined that Bob is the ideal leader among a strong pool of internal and external candidates. Bob possesses the skill set necessary to guide the next phase of Olympus' transformation, including quality and regulatory initiatives.
Bob holds a bachelor's degree in marketing from Cleveland State University and an MBA in finance from Case Western Reserve University, USA. He currently resides in Colorado and will be located in Olympus global headquarters in Tokyo, with his wife.
About Olympus
At Olympus, we are committed to Our Purpose of making people's lives healthier, safer and more fulfilling. As a global medical technology company, we partner with healthcare professionals to provide innovative solutions and services for early detection, diagnosis and minimally invasive treatment, aiming to improve patient outcomes by elevating the standard of care in targeted disease states. For more than 100 years, Olympus has pursued a goal of contributing to society by producing products designed with the purpose of delivering optimal outcomes for its customers around the world. For more information, visit https://www.olympus-global.com/ and follow our global X account: @Olympus_Corp.
Media contact:
Mail: [email protected]
Olympus Corp [TYO: 7733] [ADR: OLYMY] [STU: OLY1] [FRA: OLYS] https://www.olympus-global.com
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
5 hours ago
- Yahoo
I followed the Japanese walking method for 30 days — here's what happened to my back pain and energy levels
When you buy through links on our articles, Future and its syndication partners may earn a commission. As a fitness editor, I'm not one for health fads and trends, but when I tried the Japanese Interval Walking Training (IWT) method a month ago, I was immediately hooked. The interval walking method originated in Japan, and is a form of HIIT training which promises to burn more fat than steady-paced walks and lower your blood pressure at the same time. A month later, I'm still doing it, and it's transformed my postnatal back pain and energy levels — read on to find out more. What is the Japanese interval walking method? As a refresher, here's what the walking workout entails: Set a timer on your watch or phone and walk for three minutes at a low intensity. This should be a 4/10 effort — you're still moving, but you should easily be able to hold a conversation with someone next to you. Then walk three minutes at a high intensity. This is a 7/10 walking effort — you should be working hard. Keep switching between paces for 30 minutes. What does the science say? Studies have found IWT has several health benefits. After three months of doing a 30-minute interval walk three times a week, participants had a lower blood pressure and cholesterol, increased leg strength, and more aerobic capacity than those who walked continuously at a moderate pace for the same time. You'll also burn more calories following the Japanese interval walking method than heading out for a steady 30-minute walk, as you'll increase your heart rate during those faster intervals. If you are walking to lose weight, it's a good idea to wear one of the best fitness trackers to see how many calories you're burning, as weight loss is the result of consuming less than you burn (often referred to as being in a calorie deficit). I'm still following the Japanese interval walking method a month later — here's why It's transformed my lower back I'm 18 months postpartum, and while I'm physically able to do pretty much everything I could before having a baby, my lower back is still suffering. I had sciatica before my pregnancy, and the added weight of carting a toddler around on my hip means I'm experiencing a lot of stiffness in my lower back postpartum. Walking is great for back pain, as it can reduce inflammation in the lower back and improve blood flow to the area. It can also increase the range of motion in the hips, which can help alleviate pain. If you are suffering from sciatica, always check with your doctor beforehand, and don't walk at a pace that feels uncomfortable on your back. Walking workouts can also work on your core strength, which can, in turn, help support and stabilize your spine, reducing pain. Think about engaging your core when you walk, keeping your back straight, and sucking your belly button into your spine. I've found that doing the Japanese interval walking method a few times a week has helped me break up long periods of sitting behind my desk with a walk, and as a result, I've not been anywhere near as stiff. Granted, some days the walk involves pushing my toddler in the running stroller and powering along, or keeping an eye on my unruly cocker spaniel, but it's become part of my routine, and one I enjoy. It's boosted my energy levels There's being tired, then there's being a mom. While I'm (thankfully) out of the days of newborn exhaustion, my baby still wakes at least once a night, so I'm still pretty far from the recommended nine hours of sleep. I've found that on days when I've averaged five hours of sleep, the Japanese interval method is much kinder on my body than heading out for a run, and I've even managed to complete the workout with a coffee in one hand (file that under mom multitasking). There's science behind these mood-altering feelings — walking can increase blood flow around the body, combating fatigue. You'll also work hard for 30 minutes and receive a flood of endorphins, the body's natural mood-boosting chemicals, when you get back through the door. What are you waiting for? Grab some sneakers and get walking. Follow Tom's Guide on Google News to get our up-to-date news, how-tos, and reviews in your feeds. Make sure to click the Follow button. More from Tom's Guide I did the 12-3-30 treadmill workout for a month — here's my results Forget running — 3 walking workouts that build lower body strength and burn calories Forget 10,000 steps — I tried 'rucking' instead of regular walking for one week, and it's a game changer
Yahoo
7 hours ago
- Yahoo
TTEC Provides Update on Potential Take Private Transaction
AUSTIN, Texas, Aug. 1, 2025 /PRNewswire/ -- TTEC Holdings, Inc. (NASDAQ:TTEC), a leading global CX (customer experience) technology and services innovator for AI-enabled CX solutions, announced today that July 31, 2025, the Board of Directors (the "Board") of TTEC Holdings, Inc. ("TTEC" or the "Company") received a letter from TTEC founder, Chairman and Chief Executive Officer, Kenneth Tuchman advising the Board that due to market conditions Mr. Tuchman has determined not to pursue his previously announced unsolicited, preliminary non-binding proposal of September 27, 2024 to acquire the outstanding shares of the Company that he and his controlled affiliates do not already own. The Board of Directors has full confidence that TTEC, led by Mr. Tuchman and TTEC's executive leadership team, will continue to thrive, as a public company, in its mission to support clients in the increasingly complex CX ecosystem. As previously reported, TTEC will release its earnings results for Q2 2025 after the market closes on Thursday, August 7, 2025. The company will then host a live webcast and conference call at 8:30 a.m. ET on Friday, August 8, 2025. ABOUT TTECTTEC (pronounced T-TEC) Holdings, Inc. (NASDAQ:TTEC) is a leading global CX (customer experience) technology and services innovator for AI-enabled digital CX solutions. Serving iconic and disruptive brands, TTEC's outcome-based solutions span the entire enterprise, touch every virtual interaction channel, and improve each step of the customer journey. Leveraging next-gen digital technology, the Company's TTEC Digital business designs, builds, and operates omnichannel contact center technology, CRM, AI and analytics solutions. The Company's TTEC Engage business delivers AI-enabled customer engagement, customer acquisition and growth, tech support, back office, and fraud prevention services. Founded in 1982, the Company's singular obsession with CX excellence has earned it leading client, customer, and employee satisfaction scores across the globe. The Company's employees operate on six continents and bring technology and humanity together to deliver happy customers and differentiated business results. To learn more, visit us at Corporate Comms Investor Relations Meredith Matthews Robert Belknapp View original content to download multimedia: SOURCE TTEC Holdings, Inc. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
7 hours ago
- Yahoo
Boron One Holdings Inc. Grants Stock Options
VICTORIA, BC / / August 1, 2025 / Boron One Holdings Inc. ("Boron One" or the "Company") [TSXV:BONE], a company dedicated to the decarbonization of Planet Earth through the responsible utilization of its boron assets, announces the issuance of 7,450,000 stock options (the "Issuance") to directors, officers, employees, and consultants of the Company, under Boron One's incentive stock option plan ("the Plan"). Each option grants the holder the right to acquire one common share of Boron One at an exercise price of $0.06 for up to five years, subject to requisite regulatory approvals and the terms outlined in the Plan. Of the newly granted options, 725,000 replace previously held options that expired unexercised, and have been reissued to the same recipients. Including the Issuance, Boron One has a total of 9,550,000 stock options outstanding, representing approximately 4.1% of its issued and outstanding common shares. Under the Company's shareholder-approved Rolling Stock Option Plan, Boron One may issue options totaling up to 10% of its issued and outstanding shares, in alignment with applicable Exchange Policy. Prior to this Issuance, the Company's most recent stock option grant occurred in January of 2021. On behalf of the Board of Directors, Tim Daniels, President About Boron One Holdings Inc. Boron One Holdings Inc. is a leading company dedicated to advancing the decarbonization of our planet through the responsible utilization of its wholly owned boron assets in Serbia. With a commitment to environmental stewardship and sustainability, Boron One aims to play a crucial role in reducing the world's carbon footprint and supporting a cleaner, greener future for us all. Headquartered in Victoria, B.C., Canada, Boron One's shares are traded on the TSX Venture Exchange under the symbol "BONE". For detailed information please see Boron One's website at or the Company's filed documents at For further information, please contact: Boron's Public Quotations: Blake Fallis, General Manager Phone: 1-250- 384-1999 or 1-888-289-3746 info@ TSX Venture: BONE Berlin: EKV US: SEC 12G3-2(B) #82-4432ERVFF OTC: ERVFF Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. SOURCE: Boron One Holdings Inc. View the original press release on ACCESS Newswire Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
